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BACKGROUND: Anaemia in pregnancy is associated with adverse maternal and fetal outcome. 
Unfortunately, in developing countries its prevalence has continued to rise. To improve the situation, 
iron supplement is routinely prescribed during pregnancy. We therefore examine the impact of the 
intervention as being currently practised in our clinical setting.  
METHODS: In total, 255 prenatal clinic attendees who had more than 8 weeks of prescribed iron 
supplements were sampled. Data was obtained on their socio-demographic features, haemoglobin 
concentration at booking, compliance with iron supplements and third trimester haemoglobin value.  
RESULTS: Observed iron supplementation compliance rate was 184(72.2%). There was a significant 
drop in mean haemoglobin (Hb) concentration between the two time points (booking Hb: 32.56±2.99; 
third trimester Hb: 31.67±3.01; mean diff: 0.89±3.04; t = 4.673; 95% CI= 0.52-1.27; p= <0.001). 
Anaemia increased from 132(51.8%) to 150(58.8%) by the third trimester. Increase in anaemia occurred 
in both iron-compliant and non-compliant groups. Non-compliance however had higher odds of 
predicting anaemia by the third trimester (OR: 1.83; 95% CI: 1.03-3.26; p: 0.04).  
CONCLUSION: Although iron supplementation is still a good intervention in developing countries, it is 
not sufficient to reduce overall prevalence of anaemia by the third trimester. There is a need to look 
beyond the approach and reinforce the importance of better feeding practices, food fortification and 
reduced frequency of pregnancies. 




INTRODUCTION   
 
Combating high incidences of maternal morbidity 
and mortality that is characteristic of low-resource 
settings has been a daunting task. Ranging from 
the plague of obstetric haemorrhage, the 
devastating effects of unsafe abortions and the 
rampaging trend of unsupervised labour to the 
scourge of maternal under-nutrition and anaemia, 
maternal health researchers day-after-day have 
battled to wrest the woman from preventable 
deaths. 
Anaemia in pregnancy, defined as 
haemoglobin concentration of less than 11 g/dL, is 
a major contributor to maternal morbidity and 
mortality in the developing world (1). For 
example, it is estimated that close to 20% of 
maternal mortalities are directly linked to anaemia 
and another 50% of maternal deaths are associated 
with it (2). Sadly, more than half of gravid women 
in these areas have low haemoglobin 
concentrations and have to grapple with its 
consequences (3).  
Iron deficiency is believed to be the most 
common cause of anaemia in pregnancy (4). 
Stemming from poor iron reserve right from birth, 
inadequate dietary intake of iron, defective iron 
absorption conferred by helminthic infestations 
and increased iron requirements due to   and 
breastfeeding has made iron deficiency anaemia 
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 [IDA] to continue to soar (5).
  
Multiple control strategies aimed at 
combating IDA were indeed adopted. Notable 
ones were enrichment and fortification of food 
items, and educational interventions to promote 
dietary changes. Although these were met with 
some success in developed countries, it was not 
the same in developing world (2,6).
 
Therapeutic 
approach in the form of iron supplementation was 
thus the promising option.
 
Advocacy for routine supplementation was 
hinged on the fact that physiological requirement 
for iron during pregnancy cannot be met by most 
diets and that even pre-pregnant iron replete 
women would be in need of iron supplements 
(7,8).
 
It was therefore suggested that pregnant 
women should receive iron supplements ranging 
from 30-120mg daily depending on geographical 
prevalence of anemia, diagnosis of anaemia and/or 
available duration for the therapy (9).  
However, the recommendation was not 
without scientific disagreement based on the 
possibility of excess iron causing polycythaemia, 
oxidative damage and triggering severe chronic 
diseases (6,10). Therefore, blanket administration 
of iron during pregnancy was not universally 
accepted though it is a popular practice in 
developing countries where it is most needed. 
Again, emerging evidences on the 
effectiveness of the prescribed iron supplements 
have been inconclusive. While some reports found 
significant contribution of the approach to 
improving maternal haemoglobin concentration 
and pregnancy outcome (11,12), others have 
refuted the claim (13,14). Thus, considerable 
amount of information remains to be learnt about 
the influence of this approach on maternal anemia 
especially in African settings. 
Therefore, this research sets out to examine 
the impact of routine iron supplementation on 
maternal anemia by third trimester in our 
environment. 
 
METHODS AND PATIENTS 
 
Study setting: This observational study was 
conducted at the department of Obstetrics and 
Gynaecology of Ekiti State University Teaching 
Hospital (EKSUTH), Ado-Ekiti, southwest 
Nigeria between February 1 and April 30, 2014. 
The hospital is a tertiary health facility that 
provides comprehensive maternity services, 
accepts referral of high risk pregnancies and 
manages complicated labour cases from primary 
and secondary health centres within the 
geopolitical region. Its average delivery rate is 
2,500 per year. 
The obstetrics unit of EKSUTH operates a 
two firm system; one firm runs its prenatal clinic 
on Wednesday while the other does so on Friday.  
As largely practised in Nigeria, depending on 
when prenatal registration was done, our patients 
are usually seen every four weeks until twenty-
eight weeks of gestation, then fortnightly until 
thirty-six weeks, and thereafter weekly until 
delivery.  Some patients are, however, seen more 
frequently when clinically indicated.  
Routinely at booking, screening and 
control/treatment of common ailments such as 
HIV infection, helminthic infestation, malaria, etc 
are done. In addition, the obstetrics unit 
administers malaria chemoprophylaxis 
(Intermittent Preventive Therapy) appropriately  
using Sulphadoxine/Pyrimethamine combination 
which is given at least twice with a minimum of 4-
weeks interval between 16 weeks and 36 weeks 
gestational age. Aside these measures, in the 
course of prenatal care, overt development of 
features of malaria/helminthic infestation are 
promptly treated. Due to subsisting high 
prevalence of anaemia in pregnancy within the 
area, we practise blanket prescription of 120mg of 
elemental iron and 5mg of folic acid as daily 
supplements for all pregnant women. 
Sampling procedure: Using a previous report of 
20% prevalence of anaemia in the last trimester 
from Calabar, Nigeria (15), we calculated that a 
sample size of 246 women would be needed for an 
acceptable error margin of 5%, standard normal 
deviate of 1.96 and a confidence interval of 95%. 
Though unlikely, we decided to sample 255 
participants to make allowance for attrition. 
Eligible women were prenatal clinic 
attendees who registered at gestational age (GA) 
≤26 weeks and whose pregnancies progressed to 
reach 35-36 weeks when recruited for the study. 
Those whot did not meet the eligibility criteria and 
patients with multiple gestation, 
haemoglobinopathy or chronic medical illnesses 
were excluded. Eligible women were sequentially 
recruited after an informed written consent in the 
order on clinic attendance until the sample size 
was reached.  
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Recruitment was at GA of 35-36 weeks, and 
participants were administered a semi-structured 
questionnaire by trained resident doctors. The 
questionnaire was used to obtain information on 
patients’ socio-demographic characteristics, 
compliance with prescribed iron supplementation, 
medication side effects (if any), possible reasons 
for non-compliance, etc. Venous blood specimen 
was then collected from them for estimation of 
their haemoglobin concentration at that GA. 
Information about the haemoglobin concentration 
of each participant at the time of prenatal care 
booking was obtained from the hospital files and 
respectively entered into the study proforma. 
In this study, hemoglobin value of less than 
11.0 g/dL was considered to be anaemia in 
pregnancy (1). The measurement of haemoglobin 
at booking and at third trimester (35-36 weeks) 
was made by spectrophotometer techniques 
(oxyhaemoglobin method). We defined 
compliance as the extent to which a patient acts in 
accordance with the prescribed dose and interval 
of the medication (16). Adherence of 80% or more 
was regarded as being compliant. 
Statistical analysis: All relevant data was entered 
into Statistical Package for Social Sciences (SPSS) 
version 17. The computer software was used to 
generate the frequency table, and the results were 
tested for significance using paired t test, chi 
square test (χ
2
) or logistic regression analysis as 
appropriate. Level of significance (α) was set at 
0.05. 
Ethical consideration: The research was 
conducted in accordance with prevailing ethical 
principles. The approval for the study was 
obtained from the Ekiti State University Teaching 




Table 1 summarizes the socio-demographic 
characteristics of respondents. Fifteen (5.9%) were 
≤24 years old, while 53(20.8%) were ≥35 years 
old; 187(73.3%) were between the ages of 25 and 
34 years. Only 23(9.0%) were singles, whilw 
others were married. Thirty five (13.7%) 
respondents had primary education, 93(36.5%) 
had secondary education and 127(49.8%) attended 
tertiary schools. 
Most of the women, 159(62.4%), were 
involved in semi-skilled jobs; less than a fifth had 
skilled jobs. Out of the studied population, 
95(37.3%) were primigravida, and 160(62.7%) 
were multigravida. Thirty0seven (14.5%) had 
unplanned pregnancy. 
 






























Table 2 shows that 132(51.8%) had anaemia at 
prenatal booking visit, but by third trimester, 
150(58.8%) were anaemic. Compliance with iron 
supplementation was found in 184(72.2%) of the 
prenatal care attendees. Among the 71(27.8%) 
women who did not comply with the iron 
prescription, 32(45.1%) related reason to 
forgetfulness, 29(40.8%) did not use it because of 
side effects (gastrointestinal upsets, constipation 
and nausea), while others attributed non-usage to 
fear of harm to baby or negligence. 
 
Variables Frequency (%) 











Marital status  
Single 23(9.0) 
Married 232(91.0) 




















Table 2: Anaemia and iron supplementation compliance  
 
Variable Frequency (%) 
Anaemic at booking?; n=255  
Yes 132(51.8) 
No 123(48.2) 
Anaemic by third trimester?; n=255  
Yes 150(58.8) 
No 105(41.2) 
Compliant with iron prescription?; n=255  
Yes 184(72.2) 
No 71(27.8) 
Reasons for non-compliance, n=71  
Forgetfulness 32(45.1) 
Side effects 29(40.8) 
Others 10(14.1) 
 
Further analysis demonstrates that out of 132 
respondents who were anaemic at the booking 
visit, 39(29.5%) did not comply with iron 
supplementation regimen (Table 3). Among those 
who were non-anaemic at booking, 32(26.0%) 
were also non-compliant with the prescribed iron. 
 





Iron compliant Total 
Yes No 
Anaemic at booking?    
Yes 93(70.5) 39(29.5) 132(100) 
No 91(74.0) 32(26.0) 123(100) 
 
By the third trimester, 101(76.5%) who had 
anaemia at booking were still anaemic while 
49(39.8%) who were previously not anaemic 
became anaemic (Table 4). Overall, an increase of 
7% in prevalence of anaemia was observed. 
 
Table 4: Relationship between anaemia at booking and at third trimester 
 
 
Variable Anaemic by third trimester Total 
Yes No 
Anaemic at booking?    
Yes 101(76.5) 31(23.5) 132(100) 
No 49(39.8) 74(60.2) 123(100) 
 
The mean haemoglobin concentration at booking 
was 32.56±2.99, and at third trimester it was 
31.67±3.01. Paired t test analysis showed a 
significant drop in mean haemoglobin 
concentration between this two time points (mean 
diff: 0.89±3.04; t = 4.673; 95% CI= 0.52-1.27; p= 
<0.001). Increased in prevalence of anaemia was 
observed in both iron compliant and non-
compliant groups.  Whereas 93(50.5%) of the 
sampled subset who were compliant with iron had 
anaemia at booking, the number increased to 
101(54.9%) by third trimester. Also, among the 
non-compliant subset, anaemia increased from 
39(54.9%) at booking to 49(69.0%) by third 
trimester. Further analysis (Table 5), however, 
showed that the non-compliance had higher odds 
of predicting anaemia by the third trimester (OR: 
1.83; 95% CI: 1.03-3.26; p: 0.04). 
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Table 5: Regression analysis of non-compliance with iron medication and anaemia by third trimester 
 
 
Variable Anaemia Total Odd ratio 95% CI P value 
Yes No 
Non-compliant       
Yes 49(69.0) 22(30.9) 71(100) 1.83 1.03-3.26 0.040* 
No 101(54.9) 83(45.1) 184(100) 1.00   
*significant at p<0.05 
 
Non-compliance with iron supplementation was 
more among respondents who were <24 years old, 
muslims, married, with secondary level of 
education, unskilled, multigravida and with 
unplanned pregnancies. However, none of the 
socio-demographic features had statistical 
significance in predicting non-compliance with 
prenatal iron supplementation (Table 6). 
 
Table 6: Predictor of non-compliance with iron supplementation 
 
Variable Non-compliant Total Adjusted 
odd ratio 
95% CI P value 
Yes No 
Age (years)       
≤24 5(33.3) 10(66.7) 15(100) 1.00   
25-34 55(29.4) 132(70.6) 187(100) 1.25 0.41-3.55 0.749 
≥35 11(20.8) 42(79.2) 53(100) 1.94 0.56-6.52 0.311 
Religion       
Christianity 64(27.0) 173(73.0) 237(100) 1.75 0.66-4.51 0.278 
Islam 7(38.9) 11(61.1) 18(100) 1.00   
Tribe       
Yoruba 59(26.6) 163(73.4) 222(100) 0.39 0.03-5.20 0.299 
Igbo 12(40.0) 18(60.0) 30(100) 0.21 0.01-3.03 0.170 
Hausa 0(0) 3(100) 3(100) 1.00   
Marital status       
Single 5(21.7) 18(78.3) 23(100) 1.00   
Married 66(28.4) 166(71.6) 232(100) 0.74 0.25-1.92 0.494 
Educational level       
Primary 11(31.4) 24(68.6) 35(100) 1.00   
Secondary 32(34.4) 61(65.6) 93(100) 0.89 0.38-1.99 0.750 
Tertiary 28(22.0) 99(78.0) 127(100) 1.64 0.72-3.67 0.250 
Occupation       
Unskilled 16(29.6) 38(70.4) 54(100) 0.66 0.26-1.64 0.364 
Semi-skilled 46(28.9) 113(71.1) 159(100) 0.69 0.30-1.50 0.332 
Skilled 9(21.4) 33(78.6) 42(100) 1.00   
Gravidity       
Primigravida 24(25.3) 71(74.7) 95(100) 1.00   
Multigravida 47(29.4) 113(70.6) 160(100) 0.82 0.46-1.44 0.479 
Pregnancy 
Planned  
      
Yes 58(26.6) 160(73.4) 218(100) 1.51 0.72-3.10 0.285 
















This study found out that after controlling 
malaria/helminthic infestation, a drop in mean 
haemoglobin concentration and 7% increase in 
prevalence of anaemia occurred among prenatal 
care attendees despite being on iron 
supplementation for more than 8 weeks with a 
compliance rate of 72.2%. Though statistical 
evidence shows that non-compliance with iron 
therapy would predict anaemia in the third 
trimester, compliance among three-quarter of the 
respondents was not sufficient to reduce the 
overall prevalence of anaemia. Surprisingly, 
increase in anaemia was observed in both 
compliant and non-compliant subsets of prenatal 
clinic attendees. 
Some researchers have called to questioning 
the effectiveness of iron supplement in reducing 
prevalence of anaemia in all populations of 
pregnant women (14,17). Though others basically 
argued that its ineffectiveness may be attributable 
to low compliance (18), a reappraisal of this 
assertion may be necessary in that in our study 
iron supplements have failed to improve anaemia 
in the presence of good compliance. 
Usually, due to poverty with attending 
inability to afford balanced diet and the problem 
of ‘too frequent and too many pregnancies’, 
women in low-resource areas tend to conceive 
with severely depleted iron store (5). Compounded 
by the habit of late prenatal care booking which 
allows less time for anemia correction (19), it is 
obvious that in resource-scarce settings we need to 
look beyond iron supplements as the only 
‘saviour’. 
It could be that the supplementation can 
reduce the extent of iron depletion in the third 
trimester (20),
 
but for women who became 
pregnant with very low or no iron stores, the 
approach may not be sufficient to prevent anemia 
by third trimester. Cogswell et al found that the 
effect of iron supplementation on anaemia by the 
third trimester is not significant (13).  
Certainly, some research works have 
demonstrated positive influence of iron 
supplements on haemoglobin concentration by the 
last trimester (11,12). However, the complex 
interplay of clinical, cultural, societal and 
economic settings may not make that finding 
generalizable. 
The World Health Organization recommends a 
30mg daily dose of elemental iron in a setting 
where prevalence of anemia in pregnancy is ˂40% 
and 60mg daily in places with higher prevalence. 
Where anaemia is diagnosed or the available 
duration for supplements will be ˂6 months, a 
daily dose of 120mg of elemental iron is suggested 
(9). In our setting, because anemia is of severe 
public health importance and duration available 
for iron supplements is often ˂6 months, we 
routinely give 120mg of elemental iron to all 
prenatal care attendees. 
In a submission by the Centers for Disease 
Control and Preventions (CDC), it noted that 
higher doses of iron do not necessarily provide 
greater benefit to pregnant women in correcting 
anaemia (21). This is possibly true in our 
observation because the high dose has not 
effectively reduced overall anemia prevalence. 
There may also be a need to exercise caution 
because of adverse effects that such dose may 
have (10). 
Compliance rate among the gravid women 
was higher than 37.2% observed in Oyo state, 
Nigeria eight years ago (22). The variation can be 
attributed to passage of time, study location and 
the degree of enlightenment of participants. 
Whereas the aforementioned study was conducted 
at primary health care level, ours was done at a 
tertiary health facility which likely skewed 
participants towards more educated ones. It is 
therefore possible that reduced compliance and 
worse prevalence of anaemia at third trimester 
would be recorded at lower levels of care. Our 
compliance rate, however, is comparable with 
studies from India and Senegal where compliance 
was 65% and 69% respectively (23,24). 
Forgetfulness and perceived side-effects 
accounts mostly for non-compliance; it is similar 
with what was found by Mithra et al (23). More 
provision of clear instruction on health benefits of 
the supplementation and tapering of the dose 
could enhance compliance. 
This study is not without social desirability 
bias. There is a tendency that since compliance 
was self-reported, actual rate may be lower. 
Compliance is best measured by continuous direct 
observation that therapies are taken (25), a process 
that is impracticable in this circumstance. 
Although there is still a tendency of 
overestimation of adherence to therapy by pill 
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counts (25), for future studies, adjoining it as a 
measure of compliance will be suggested. 
Predicting who will not comply with iron 
supplementation was difficult as none of the 
socio-demographic features was associated with 
non-compliance. Some studies, however, found 
that non-compliance was more among singles, 
teens and increasing maternal age (22,23). 
It is uncertain if weekly iron 
supplementation will produce similar/better 
compliance and therapeutic effects in our 
environments as compared to daily regimen, but 
considering the stage of our socio-cultural 
evolvement, it may produce a lower compliance. 
However, it is worth investigating. Also, 
comparison of the impact of slow iron gastric-
delivery system to high daily elemental iron doses 
in low-income settings can be researched into.  
More needs to be learnt about how to 
safeguard pregnant women in resource-scarce 
settings from going into delivery process with sub-
optimal hemoglobin concentration. It is evident 
that dependence on prenatal iron supplementation 
may not be the sole solution. There is a need to 
look beyond the approach and reinforce the 
importance of better feeding practices, food 
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